C2i Genomics, Inc.
New York, US · Founded 2019 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
AZ
Asaf ZviranExecutive Officer, Director
ES
Ezra SoferExecutive Officer, Director
EC
Eli CasdinDirector
AP
Alex ParkerDirector
SR
Shaun RodriguezDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$50MraisedApr 2021 · 16 investors · BiotechnologyRule 506(b)
▶$50MraisedApr 2021 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eli CasdinDirector
- Asaf ZviranExecutive Officer, Director
- Alex ParkerDirector
- Ezra SoferExecutive Officer, Director
- Shaun RodriguezDirector
- Offering amount
- $100M
- Amount sold
- $50M
- Minimum investment
- $75K
- Proceeds to insiders
- $500K
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$12MraisedJun 2020 · 8 investors · BiotechnologyRule 506(b)
▶$12MraisedJun 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Omri Amirav-DroriDirector
- Shaun RodriguezDirector
- Ezra SoferExecutive Officer, Director
- Asaf ZviranExecutive Officer, Director
- Eli CasdinDirector
- Offering amount
- $12M
- Amount sold
- $12M
- Minimum investment
- $70K
- Proceeds to insiders
- $450K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.